Evidence map›Paper›PMID 26209057›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2015

Arterial α2-Na+ pump expression influences blood pressure: lessons from novel, genetically engineered smooth muscle-specific α2 mice.

Ling Chen, Hong Song, Youhua Wang, Jane C Lee, Michael I Kotlikoff, Tracy J Pritchard, Richard J Paul, Jin Zhang, Mordecai P Blaustein

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Sensational site: the sodium pump ouabain-binding site and its ligands.American journal of physiology. Cell physiology · 2024
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Pivotal role of α2 NaThe Journal of physiology · 2016
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ling ChenDepartment of Physiology, University of Maryland School of Medicine, Baltimore, Maryland; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland;
Hong SongDepartment of Physiology, University of Maryland School of Medicine, Baltimore, Maryland;
Youhua WangDepartment of Physiology, University of Maryland School of Medicine, Baltimore, Maryland;
Jane C LeeDepartment of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York;
Michael I KotlikoffDepartment of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York;
Tracy J PritchardCollege of Nursing, College of Medicine, University of Cincinnati, Cincinnati, Ohio; and.
Richard J PaulDepartment of Molecular and Cell Physiology, College of Medicine, University of Cincinnati, Cincinnati, Ohio.
Jin ZhangDepartment of Physiology, University of Maryland School of Medicine, Baltimore, Maryland;
Mordecai P BlausteinDepartment of Physiology, University of Maryland School of Medicine, Baltimore, Maryland; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland; mblaustein@som.umaryland.edu.
University of Maryland, Baltimore · USCornell University · USUniversity of Cincinnati Medical Center · US

Funding

Sympathetic Neurotransmitters and Ouabain HypertensionP01HL078870 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI BLAUSTEIN, MORDECAI P · 2005 to 2009
$9.9M
Na+/Ca2+ Exchanger type-1 in Arterial Contraction and Salt-induced HypertensionR01HL107654 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI WIER, WITHROW GIL · 2011 to 2015
$1.8M
Alpha-2 Na+ Pumps, [Ca2+], Arterial Contraction & HypertensionR01HL107555 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI BLAUSTEIN, MORDECAI P · 2012 to 2015
$1.5M
NHLBI NIH HHS P01-HL-78870NHLBI NIH HHS R01-HL-107555NHLBI NIH HHS R01-HL-107654
6 · The paper itself

Abstract

Arterial myocytes express α1-catalytic subunit isoform Na(+) pumps (75-80% of total), which are ouabain resistant in rodents, and high ouabain affinity α2-Na(+) pumps. Mice with globally reduced α2-pumps (but not α1-pumps), mice with mutant ouabain-resistant α2-pumps, and mice with a smooth muscle (SM)-specific α2-transgene (α2 (SM-Tg)) that induces overexpression all have altered blood pressure (BP) phenotypes. We generated α2 (SM-DN) mice with SM-specific α2 (not α1) reduction (>50%) using nonfunctional dominant negative (DN) α2. We compared α2 (SM-DN) and α2 (SM-Tg) mice to controls to determine how arterial SM α2-pumps affect vasoconstriction and BP. α2 (SM-DN) mice had elevated basal mean BP (mean BP by telemetry: 117 ± 4 vs. 106 ± 1 mmHg, n = 7/7, P < 0.01) and enhanced BP responses to chronic ANG II infusion (240 ng·kg(-1)·min(-1)) and high (6%) NaCl. Several arterial Ca(2+) transporters, including Na(+)/Ca(2+) exchanger 1 (NCX1) and sarcoplasmic reticulum and plasma membrane Ca(2+) pumps [sarco(endo)plasmic reticulum Ca(2+)-ATPase 2 (SERCA2) and plasma membrane Ca(2+)-ATPase 1 (PMCA1)], were also reduced (>50%). α2 (SM-DN) mouse isolated small arteries had reduced myogenic reactivity, perhaps because of reduced Ca(2+) transporter expression. In contrast, α2 (SM-Tg) mouse aortas overexpressed α2 (>2-fold), NCX1, SERCA2, and PMCA1 (43). α2 (SM-Tg) mice had reduced basal mean BP (104 ± 1 vs. 109 ± 2 mmHg, n = 15/9, P < 0.02) and attenuated BP responses to chronic ANG II (300-400 ng·kg(-1)·min(-1)) with or without 2% NaCl but normal myogenic reactivity. NCX1 expression was inversely related to basal BP in SM-α2 engineered mice but was directly related in SM-NCX1 engineered mice. NCX1, which usually mediates arterial Ca(2+) entry, and α2-Na(+) pumps colocalize at plasma membrane-sarcoplasmic reticulum junctions and functionally couple via the local Na(+) gradient to help regulate cell Ca(2+). Altered Ca(2+) transporter expression in SM-α2 engineered mice apparently compensates to minimize Ca(2+) overload (α2 (SM-DN)) or depletion (α2 (SM-Tg)) and attenuate BP changes. In contrast, Ca(2+) transporter upregulation, observed in many rodent hypertension models, should enhance Ca(2+) entry and signaling and contribute significantly to BP elevation.

Indexed as

Blood PressureAngiotensin IIAnimalsArteriesMiceMuscle CellsMuscle, Smooth, VascularPlasma Membrane Calcium-Transporting ATPasesProtein SubunitsSarcoplasmic Reticulum Calcium-Transporting ATPasesSodium-Calcium ExchangerSodium-Potassium-Exchanging ATPaseAngiotensin IIAtp2a2 protein, mouseAtp2b1 protein, mouseNCX1 protein, mousePlasma Membrane Calcium-Transporting ATPasesProtein SubunitsSarcoplasmic Reticulum Calcium-Transporting ATPasesSodium-Calcium ExchangerSodium-Potassium-Exchanging ATPaseangiotensin IIblood pressureNa+/Ca+ exchanger 1saltsarco(endo)plasmic reticulum Ca2+-ATPase 2α2-Na+ pump

Identifiers

PMID26209057
PMCPMC4591399
OpenAlexW1879334119

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.